Breast Cancer Response to Methotrexate and Oestradiol
Author Information
Author(s): R. Clarke, H.W. Van den Berg, D.G. Kennedy, R.F. Murphy
Primary Institution: The Queen's University of Belfast
Hypothesis
How does oestrogen receptor status influence the response of breast cancer cell lines to methotrexate and oestradiol?
Conclusion
Oestradiol can protect non-responsive breast cancer cells from methotrexate while enhancing its effects on responsive cells.
Supporting Evidence
- Oestradiol significantly reduced the effects of methotrexate in the MDA-MB-436 cell line.
- Oestradiol potentiated the action of methotrexate in the MCF-7 cell line.
- Pharmacological concentrations of oestradiol reduced intracellular levels of methotrexate.
Takeaway
This study shows that oestradiol can help some breast cancer cells grow while making other cells more sensitive to a cancer drug called methotrexate.
Methodology
The study involved treating two breast cancer cell lines with methotrexate and oestradiol and measuring their growth and drug levels.
Limitations
The study is limited to in vitro conditions and may not fully represent in vivo responses.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website